HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$24.46
Day range
$24.30 - $26.52
Year range
$1.54 - $38.50
Market cap
154.60M USD
Avg Volume
81.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.57M | -23.77% |
Net income | -1.30M | 33.24% |
Net profit margin | — | — |
Earnings per share | -1.85 | -164.29% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.02M | -29.13% |
Total assets | 6.07M | -29.37% |
Total liabilities | 1.12M | -43.34% |
Total equity | 4.95M | — |
Shares outstanding | 5.28M | — |
Price to book | 17.47 | — |
Return on assets | -59.43% | — |
Return on capital | -71.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.30M | 33.24% |
Cash from operations | -1.07M | 44.66% |
Cash from investing | 985.73K | 7,652.33% |
Cash from financing | -16.53K | -106.70% |
Net change in cash | -99.85K | 94.12% |
Free cash flow | -740.34K | 43.07% |
About
Founded
2014
Headquarters
Website
Employees
10
